Artificial Intelligence in Life Sciences Market Size, Share - Growth Analysis Report and Forecast Trends (2026-2035)

The global artificial intelligence in Life Sciences market was valued at USD 2.75 billion in 2025. It is poised to grow at a CAGR of 24.70% during the forecast period of 2026-2035, and reach USD 25.05 billion by 2035. The market growth is driven by the rising demand for data-driven insights, increasing R&D complexity, and growing adoption of AI solutions, with real-world evidence enhancing decision-making and accelerating innovation across life sciences.

Key Market Trends and Insights

• By region, North America is expected to dominate the market globally, accounting for the largest revenue share of nearly 49% in the historical period.
• Based on deployment, the cloud segment is anticipated to lead the market, capturing the largest revenue share of Approximately 51% in the historical period.
• Based on end user, the pharmaceutical and biotechnology companies segment held the leading position, with the highest revenue share of above 45% in the historical period.

Market Size and Forecast

• Market Size (2025): USD 2.75 billion
• Projected Market Size (2035): USD 25.05 billion
• CAGR (2026-2035): 24.70%

Artificial Intelligence in Life Sciences Market Overview

Artificial Intelligence (AI) in life sciences is transforming research, drug development, and healthcare delivery by enabling advanced data analytics and predictive modeling. The increasing R&D complexity and demand for faster outcomes are accelerating adoption across the sector. AI-driven tools support genomics, clinical research, and precision medicine initiatives. Additionally, the growing use of real-world evidence is enhancing decision-making, improving patient outcomes, and driving innovation across the global life sciences market. The market reached a value of approximately USD 2.75 billion in 2025.

Artificial Intelligence in Life Sciences Market Growth Drivers

Increasing AI-Enabled Drug Discovery Driving the Market Expansion

Rising demand for faster, cost-efficient drug development and optimized research workflows is propelling market growth. For instance, in January 2026, major life sciences companies, including Lilly and NVIDIA, implemented the BioNeMo AI platform, enhancing predictive modeling and laboratory automation. This adoption supports early-stage drug-target interaction analysis, improving research efficiency and accelerating AI integration across pharmaceutical and biotechnology development globally, driving innovation and operational improvements across the life sciences sector.

Artificial Intelligence in Life Sciences Market Trends

Key trends shaping the market include increasing AI adoption, regulatory advancements, data-driven research expansion, and growing investments accelerating innovation and market growth.

Advancing Regulatory AI Adoption Accelerating the Market Demand

Increasing regulatory complexity and rising demand for efficient compliance processes are key trends shaping market development. For instance, in March 2026, the FDA Group launched AICA, an AI-powered platform designed to automate quality management system audits and streamline compliance workflows. This advancement is expected to accelerate adoption of regulatory AI, enhancing audit efficiency, reducing timelines, and supporting scalable growth across the artificial intelligence in life sciences market.

Artificial Intelligence in Life Sciences Market Segmentation

Market Breakup by Offering

• Software
• Hardware
• Services

Market Breakup by Deployment

• On-Premises
• Cloud

Market Breakup by Application

• Research and Development
• Drug Discovery and Clinical Trials
• Biotechnology
• Surgery and Treatment
• Precision and Personalized Medicine
• Medical Diagnosis
• Patient Monitoring
• Others

Market Breakup by End User

• Healthcare Providers
• Pharmaceutical and Biotechnology Companies
• Patients
• Payer
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Artificial Intelligence in Life Sciences Market Share

Cloud Segment Expected to Lead the Market Share by Deployment

The cloud segment dominated the market by deployment, accounting for more than 51% share in the historical period, driven by scalability, cost efficiency, and seamless data integration capabilities. Cloud-based platforms enable real-time analytics and support collaborative research across organizations. The increasing reliance on digital infrastructure is further strengthening data-driven research, enabling enhanced data accessibility, improved decision-making, and accelerated innovation across life sciences research and development activities globally.

Global Artificial Intelligence in Life Sciences Market Analysis by Region

North America dominated the market, accounting for approximately 49% share in the historical period, supported by advanced technological infrastructure and strong investment in research. The region benefits from early adoption of AI-driven solutions across healthcare and pharmaceutical sectors. Increasing implementation of AI technologies is enhancing laboratory automation, improving data accuracy, streamlining workflows, and supporting efficient research and development processes across life sciences organizations.

Leading Players in the Artificial Intelligence in Life Sciences Market

The key features of the market report comprise patent analysis, funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:

IBM Corporation

IBM Corporation, headquartered in Armonk, New York, United States, and established in 1911, is a global technology leader offering AI-driven solutions for life sciences. Its portfolio includes advanced analytics, cloud platforms, and Watson-based tools supporting data-driven research, enabling pharmaceutical companies to enhance decision-making, optimize workflows, and improve overall research efficiency across drug discovery and development processes.

NuMedii Inc.

NuMedii Inc., headquartered in San Mateo, California, United States, and founded in 2008, focuses on AI-powered drug discovery using big data and bioinformatics. The company leverages advanced algorithms to identify novel therapeutic opportunities, emphasizing computational biology to uncover disease mechanisms, accelerate drug repurposing, and improve success rates in pharmaceutical research and development initiatives globally.

Atomwise Inc

Atomwise Inc., based in San Francisco, California, United States, and established in 2012, specializes in AI-driven drug discovery using deep learning technologies. Its platform enables rapid identification of potential drug candidates through virtual screening, focusing on drug-target interaction to predict molecular binding and optimize compound selection, significantly enhancing efficiency and accuracy in early-stage pharmaceutical research.

AiCure LLC

AiCure LLC, headquartered in New York, United States, and founded in 2010, provides AI-based solutions to improve patient engagement and clinical trial outcomes. Its platform uses computer vision and advanced analytics to monitor medication adherence, supporting regulatory AI compliance and data integrity. AiCure’s solutions enhance trial efficiency, improve data accuracy, and strengthen overall pharmaceutical development processes.

Other key players in the market are Nuance Communications Inc., Databricks, IQVIA, SAS Institute Inc., Sorcero, and Indegene.

Key Questions Answered in the Artificial Intelligence in Life Sciences Market Report

• What was the artificial intelligence in Life Sciences market value in 2025?
• What is the artificial intelligence in Life Sciences market forecast outlook for 2026-2035?
• What major factors aid the demand for artificial intelligence in Life Sciences market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market’s major drivers, opportunities, and restraints?
• What are the major artificial intelligence in Life Sciences market trends?
• Which offering is expected to dominate the market segment?
• Which deployment is projected to lead the market segment?
• Which application is likely to lead the market segment?
• Which end user is likely to dominate the market segment?
• Who are the key players in the artificial intelligence in Life Sciences market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?